Epigenica Closes $2.2 Million Investment Round to Scale Cutting-Edge Epigenetic Solutions

Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market     STOCKHOLM, Sweden, June 30th, 2025 – Epigenica AB , a pioneer in high-throughput epigenetic screening tools and solutions, announced today that it has closed a $2.2 million round (SEK 21.5M) to fuel its growth and commercial expansion across key markets. This round was led by Voima Ventures , a Nordic early-stage investor that specializes in supporting science-based solutions. Deep tech investor Navigare Ventures (